Showing results (161-170 of 357) with videos related to
Sort By:
Pageof 36
Clinical Endocrinology|January 1, 1988
Effect of a new somatostatin analogue SMS 201-995 (Sandostatin) on the renin-aldosterone axisC Sieber, M Gnädinger, E Del Pozo, et al.Journal of Hypertension|April 1, 1986
Body sodium/blood volume state in normotensive members of normotensive and hypertensive familiesC Beretta-Piccoli, A Fischbacher, A Rothenbühler, et al.Hypertension (Dallas, Tex. : 1979)|September 1, 1982
Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjectsK Boehringer, C Beretta-Piccoli, P Weidmann, et al.Schweizerische Medizinische Wochenschrift|September 5, 1992
[Diagnostic value of ambulatory daily blood pressure profile: comparison with measurements performed by a laboratory technician]P Ferrari, E Ostini, Y Allemann, et al.Journal of Cardiovascular Pharmacology|March 1, 1986
Comparative acute effects of the calcium channel blockers tiapamil, nisoldipine, and nifedipine on blood pressure and some regulatory factors in normal and hypertensive subjectsK Laederach, P Weidmann, F Lauener, et al.Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1976
Blood pressure, circulating renin and the body sodium/volume state in patients with mild renal failureC Beretta-Piccoli, P Weidmann, R de Chatel, et al.European Journal of Clinical Pharmacology|January 1, 1989
Antihypertensive and hypouricaemic effects of nitrendipine in chronic renal failureP Weidmann, M P Gnädinger, D Schohn, et al.Journal of Human Hypertension|April 1, 1989
Hypotensive and diuretic effects of atrial natriuretic factor in diabetic patientsC Pusterla, C Beretta-Piccoli, P Weidmann, et al.Journal of Human Hypertension|March 1, 1988
Sodium and responses to infused noradrenaline and angiotensin II in subjects predisposed to hypertensionC Pusterla, C Beretta-Piccoli, P Städler, et al.European Journal of Clinical Pharmacology|January 1, 1981
Chronic treatment with the new potent vasodilator Ro 12-4713 in moderate to severe hypertension: effects on blood pressure, endocrine function, sodium and plasma volumeM Grimm, P Weidmann, A Meier, et al.Pageof 36